Equity Research Report: Occidental Petroleum Corporation ($OXY)
Current Price: $58.42 | Rating: BUY | Fair Value: $67 | 12-Mo Target: $65
One-Page Summary
OXY is a best-in-class Permian operator transforming into a hybrid E&P / carbon-management franchise, with a 29% Berkshire Hathaway anchor that effectively floors the equity. Following the $9.7B OxyChem divestiture (closed Jan 2, 2026), principal debt has fallen from $20.8B to $13.3B, putting management on track for its $10B target by year-end and clearing the runway for buyback re-initiation. With Stratos DAC commercial startup imminent in Q2 2026 and the stock trading at 6.4x EV/EBITDA (a steep discount to CVX 10.8x and XOM 12.0x), the risk/reward favors patient accumulation on pullbacks toward $45–50.
Top 5 Reasons to Own:
- Berkshire put at ~$59.62 warrant strike — Buffett's 29% common stake + warrants create an unusual structural floor not captured in DCF.
- Permian breakeven $40–45/bbl WTI vs. $65–70 strip — multi-decade inventory runway post-CrownRock at 1.45M boe/d.
- DAC optionality is a free call — Stratos 500kt/yr nameplate locks in $90M/yr at $180/MT 45Q floor; Bain, Amazon, Microsoft, BlackRock offtake validates the carbon stream.
- Deleveraging re-rating — $7.5B debt cut in 7 months drops annual interest by $550M; ratings upgrade + buyback initiation are live catalysts.
- Cheapest large-cap E&P on EV/EBITDA — 6.4x vs. ~9x sector average with above-peer Permian acreage quality.
1. Company Overview
Occidental Petroleum is an oil & gas producer with 1.45M boe/d of production, anchored by 1.3M net Permian Basin acres (Midland + Delaware) following the 2024 CrownRock acquisition. Post-OxyChem divestiture to Berkshire (Jan 2, 2026), the company is a near-pure-play upstream operator with a strategic carbon-management arm: 1PointFive owns the proprietary Carbon Engineering DAC technology and is commissioning Stratos, the world's first commercial-scale DAC plant (500,000 MT/yr) in West Texas. OXY operates 5,100+ miles of CO₂ pipeline infrastructure — the largest US footprint — enabling a closed-loop capture-and-EOR model that monetizes IRA 45Q credits ($180/MT geological storage, $130/MT EOR) while also lifting oil recovery economics.
2. Price Chart
3. Technical Setup
Trend
OXY is in a strong uptrend with +10.16% weekly and +33.32% annual gains, trading $7.82 below the 200-day high ($66.24) and well above the 200-day low ($38.92), indicating sustained bullish momentum with room to the 5-year peak.
Wyckoff Phase
Phase C (Late Markup) — price is advancing toward R1 resistance with volume-driven momentum, suggesting buyers are in control but approaching a potential distribution zone near the 200-day high.
Key Levels
| Level | Price | Significance |
|---|---|---|
| R2 | $75.97 | 5-yr peak resistance |
| R1 | $66.24 | 200-day swing high |
| S1 | $38.92 | 200-day swing low |
| S2 | $21.95 | 5-yr capitulation low |
Entry Strategy
- Bullish: Buy zone $38.92—$45.00 (S1 region pullback), stop loss $21.50 (just below S2)
- Bearish: Short zone $64.00—$66.24 (near R1), stop loss $76.50 (above R2)
Ant's Verdict
WAIT FOR PULLBACK — Target a retest of $45—$50 support before re-entry; if R1 ($66.24) breaks on volume, next target is R2 ($75.97) within 4—6 months.
4. Financial Health
Business Quality
Moat Width: Narrow
- Permian Basin Scale & Low-Cost Acreage: With 1.3M net acres in the Permian and production of ~1,426 Mboed post-CrownRock, OXY operates one of the lowest-breakeven Permian positions of any independent — full-cycle breakeven of $40–45/bbl WTI on core Midland Basin inventory, below current strip.
- Carbon Management Optionality (1PointFive / Stratos): OXY holds proprietary Carbon Engineering DAC technology and is commissioning Stratos (500,000 MT/yr). The "One Big Beautiful Bill" signed July 4, 2025 preserved 45Q credits at $180/MT geological storage / $130/MT EOR. Contracted offtake with Amazon, Microsoft, and BlackRock provides revenue visibility.
- OXY Enhanced Oil Recovery Expertise: Largest US CO₂-EOR operator with 5,100+ miles of CO₂ pipeline; closed-loop synergy with Stratos captured CO₂ monetizes both 45Q credit and incremental oil recovery at near-zero marginal cost.
Financial Snapshot
| Metric | Value | Source | Assessment |
|---|---|---|---|
| Revenue TTM | $20.34B | stockanalysis.com | Reflects OxyChem divestiture; Q1 2026 run-rate of ~$20.4B annualized (continuing ops only) |
| Revenue Prior Q (Q1 2026) | $5.11B | OXY Q1 2026 Press Release (May 5, 2026) | Missed consensus of $5.45B; down 25% YoY due to OxyChem removal |
| Free Cash Flow TTM | $3.37B | Q1 2026 $1.747B FCF before WC | Strong; Q1 FCF before WC annualizes to ~$7B at current oil prices |
| Cash on Hand | $3.81B | Yahoo Finance | Adequate; debt paydown is priority over cash accumulation |
| EBITDA TTM | $10.83B | stockanalysis.com | EV/EBITDA 6.42x — discount to CVX (10.8x) and XOM (12.0x) |
| Profit Margin | ~19.9% (TTM) | Q1 GAAP NI $3.2B / $5.11B rev | Inflated by one-time $3.1B OxyChem gain; adjusted margin ~21% on ops |
| Book Value | ~$32.10/share | Gurufocus + Q1 accretion | P/B of 1.82x at $58.42 — fair for Permian-heavy E&P |
| EPS TTM | $3.99 | stockanalysis.com | Q1 2026 adj. EPS $1.06 vs. $0.61 consensus — 74% beat |
| Debt/Equity | 0.42 (improving) | Debt cut to $13.3B as of May 5, 2026 from $20.8B at Q3 2025 | Structurally improving; targeting $10B principal by year-end |
| P/E (TTM) | 14.63x ($58.42 / $3.99) | Calculated | Cheap vs. sector; reflects commodity earnings volatility discount |
| Forward P/E | 10.8–13.5x | Two estimates diverge (2026 EPS est. $4.34) | Below CVX (11.9x) on FY guidance strip |
Valuation vs. Peers
| Metric | OXY | CVX | XOM | Sector Avg (E&P Large-Cap) |
|---|---|---|---|---|
| P/E (TTM) | 14.6x | 32.4x | 25.7x | ~22x |
| Forward P/E | 10.8–13.5x | 11.9x | 12.5x | ~13x |
| P/B | 1.82x | 2.00x | 2.49x | ~2.1x |
| EV/EBITDA | 6.42x | 10.8x | 12.0x | ~9x |
| Revenue Growth (YoY, est. 2026) | +16.2% (continuing ops adj.) | ~flat | +1.7% | ~2–4% |
| Profit Margin | ~19.9% (incl. OxyChem gain) / ~11% adj. | 5.9% | 7.8% | ~10% |
Notes: COP Forward P/E ~12.8x, EV/EBITDA ~6.6–7.2x; DVN Forward P/E ~12.5x, EV/EBITDA ~4.5x; EOG EV/EBITDA ~6.6x. OXY trades at the steepest EV/EBITDA discount to CVX and XOM, but at a modest premium to DVN, justified by superior Permian acreage quality and DAC optionality.
5. Ownership & Capital Structure
Top Strategic / Active Institutional Holders
| Holder | Shares Held | % Outstanding | Notes |
|---|---|---|---|
| Berkshire Hathaway | ~264.9M–348.9M (range per filings) | ~26.8–32.7% | Largest holder; bought OxyChem for $9.7B (closed Jan 2, 2026); still accumulating in 2026, pace slowing |
| Vanguard Group | 80.2M | 8.53% | 13G/A filed Apr 2025; +41% YoY — partially active, partially index |
| Dodge & Cox | 74.1M | 7.5% | 13G/A filed Q1 2026; active value manager — meaningful active conviction holder |
State Street data not confirmed as active vs. index-weight. Pure-index ETF flows excluded per mandate.
Recent Funding / Capital Events
- OxyChem Sale (Jan 2, 2026): $9.7B cash received from Berkshire; ~$5.8–6.5B directed to debt repayment; generated $3.1B after-tax gain in Q1 2026 discontinued operations.
- Debt Paydown: Total principal debt reduced from $20.8B (Q3 2025) to $13.3B as of May 5, 2026 — a $7.5B reduction in ~7 months. Annual interest run-rate now $845M, down $550M YoY. Target: $10B principal debt by year-end 2026.
- CrownRock Funding: $12B acquisition (closed mid-2024) funded via ~$9.1B in new debt + ~$1.7B equity issuance + asset sales. Integration complete; Permian production boosted ~8% YoY.
- No equity raises planned. Capital allocation priority: debt reduction → dividend maintenance (1.78% yield, $0.26/qtr after 8%+ hike in Feb 2026) → buybacks once debt hits $15B target (already cleared via OxyChem proceeds).
6. Competition & Sector
Competitor Comparison
| Company | Ticker | Market Cap | EV/EBITDA | Forward P/E | Profit Margin | Key Differentiator |
|---|---|---|---|---|---|---|
| Chevron | CVX | ~$286B | 10.8x | 11.9x | 5.9% | Integrated major; Kazakhstan Tengiz ramp |
| ExxonMobil | XOM | ~$479B | 12.0x | 12.5x | 7.8% | Largest integrated; Pioneer acquisition synergies |
| ConocoPhillips | COP | ~$132B | 6.6–7.2x | 12.8x | 12.3% | Pure-play E&P; MPLX position; Marathon acquisition |
| Devon Energy | DVN | ~$18B | 4.5x | 12.5x | 16.5% | Permian/Eagle Ford; variable dividend model |
| EOG Resources | EOG | ~$65B | 6.6x | ~12x | ~18% | Premium returns discipline; international diversification |
| Occidental | OXY | $58.1B | 6.42x | 10.8–13.5x | ~11% adj. | Permian scale + DAC tech + CO₂-EOR moat |
Tailwinds
- OPEC+ Production Discipline: UAE departure (May 2026) reduces OPEC spare capacity to ~2.5 Mb/d by 2027 vs. prior 3.8 Mb/d forecast; structural floor under prices.
- Permian Basin Cost Curve: OXY's Midland Basin breakeven ~$40–45/bbl WTI — profitable above current strip of ~$65–70/bbl; multi-decade inventory runway post-CrownRock.
- IRA 45Q DAC Credit Preservation: "One Big Beautiful Bill" (signed Jul 4, 2025) maintained $180/MT DAC geological storage credit and equalized EOR utilization credit to same rate.
- Debt De-leveraging Re-rating: Debt target $10B by end-2026 (vs. $20.8B peak); credit profile and FCF/share improve materially; buyback initiation triggers re-rating.
- Carbon Credit Market Growth: Amazon, Microsoft, BlackRock, Bain offtake validates voluntary carbon market at $300–400/MT vs. 45Q floor of $180/MT.
Headwinds
- Oil Price Volatility: IEA/EIA divergence — $65–75/bbl base case vs. geopolitical $89–106/bbl swings; OXY has no refining buffer (unlike CVX/XOM), so earnings are highly price-sensitive.
- Stratos Execution Risk: Already delayed from end-2024 to Q2 2026; commercial-scale DAC has never operated at this size.
- Debt Overhang: $13.3B principal debt remains elevated per-barrel vs. peers; sustained WTI <$50/bbl would stress FCF and slow deleveraging.
- Regulatory / Policy Risk: 45Q interpretation could shift; voluntary carbon market remains illiquid.
- Post-OxyChem Revenue Concentration: OxyChem contributed $3–4B/yr at higher margins; its removal raises OXY's earnings beta to crude.
7. 12-Month Catalyst Timeline
| Date / Quarter | Catalyst | Type | Expected Impact |
|---|---|---|---|
| Q2 2026 (Jun–Jul) | Stratos DAC Phase 1 commercial operations commencement | Operational / Strategic | Positive — first commercial DAC revenues + 45Q credit recognition; validates technology at scale |
| Jun 1, 2026 | CEO transition: Vicki Hollub retires, Richard Jackson (COO) succeeds | Governance | Mixed — continuity on Permian ops; loss of CrownRock/OxyChem architect |
| Aug 4–5, 2026 | Q2 2026 Earnings Report | Financial | Positive if WTI stays $65+; key read on debt trajectory and Stratos ramp |
| Q3 2026 (Sep) | OPEC+ Ministerial Meeting | Macro / Commodity | Swing factor — production policy sets WTI trajectory for H2 2026 |
| Sep–Oct 2026 | Debt milestone: $10B principal target | Financial / Credit | Potential trigger for buyback announcement; credit re-rating upward |
| Nov 2026 | Q3 2026 Earnings Report | Financial | Key read on Stratos credit monetization cadence and full-year FCF realization |
| Q4 2026 | FOMC rate trajectory | Macro | Lower rates reduce $845M annual interest burden; improve DCF valuation |
| Q4 2026 / Q1 2027 | Stratos Phase 2 ramp toward 500,000 MT/yr nameplate | Operational | Long-dated positive; full capacity = ~$90M annual 45Q revenue at $180/MT floor |
8. Recent News
| Date | Outlet | Headline | Material? |
|---|---|---|---|
| May 6, 2026 | Benzinga / Investing.com | Occidental Q1 2026 beats EPS at $1.06 vs. $0.58 consensus; $1.7B FCF generated; stock falls on full-valuation concerns | Yes |
| May 3, 2026 | CNBC | OPEC+ announces 188,000 bpd output increase at first meeting without UAE; Brent averaging $117/bbl in April on Hormuz disruption | Yes |
| May 1, 2026 | GlobeNewswire / StockTitan | Occidental announces CEO succession: Vicki Hollub retires June 1, COO Richard Jackson named successor at $1.4M base salary | Yes |
| Apr–May 2026 | RBN Energy / Oil Gas Leads | Stratos DAC Phase 1 nears Q2 2026 startup; commissioning underway on first of two units; Bain & Co. purchases 9,000 MT of CDR credits | Yes |
| Apr 17, 2026 | MarketBeat / Daily Political | OXY shares gap down on analyst downgrade to Hold; analyst cites full valuation and easing Middle East tensions reducing oil-price premium | Yes |
| Mar 20, 2026 | Benzinga | JP Morgan raises OXY price target to $63; Piper Sandler upgrades to Overweight at $66; HSBC lifts to Buy at $68 | Yes |
| Feb 19, 2026 | FinancialContent / MarketMinute | Occidental surges 9.4% as Q4 2025 earnings crush estimates amid rising crude prices; dividend lifted 8%+ to $0.26/qtr | Yes |
| Jan 2, 2026 | GlobeNewswire / World Oil | Occidental completes $9.7B sale of OxyChem to Berkshire Hathaway; uses $5.8B of proceeds to cut principal debt toward $15B target | Yes |
9. M&A & Rumor Watch
- Berkshire Hathaway OxyChem close (Jan 2, 2026): Berkshire paid $9.7B cash for OxyChem, simultaneously cementing its position as OXY's largest common equity holder. Berkshire's OXY common stake is ~29% (~244M shares per latest 13F). No warrants converted; warrants struck at $59.62 — almost exactly current price — mean Berkshire could reach ~40%+ on exercise, a standing acquisition option the market has not fully priced.
- Dodge & Cox disclosed a 7.5% passive stake via amended Schedule 13G/A in early 2026 — second anchor institutional holder.
- ADNOC/XRG joint venture: OXY and Abu Dhabi's XRG agreed to evaluate a JV to develop a South Texas Direct Air Capture Hub, a potentially material new revenue stream announced in Q1 2026 — no deal closed yet.
- No credible third-party M&A bids or activist campaigns beyond CrownRock integration (fully absorbed; total production 1.45M boe/d).
10. Social Sentiment
- Overall mood: Bullish
- Retail vs. Institutional: Retail is firmly Buffett-following — the 29% Berkshire stake serves as a psychological floor and the most-cited bull argument on Reddit, X, and Seeking Alpha. ApeWisdom sentiment climbed from quarterly 73.2 to weekly 81.1 through April. Institutional desks split: bulls at Piper Sandler, HSBC, Wells Fargo ($66–$72 targets) cite $7B annualized FCF, debt paydown velocity, 8% dividend hike; bears (Goldman Sachs, Sell-rated) flag oil-price mean reversion as Hormuz tensions ease and OPEC+ adds barrels.
- Trending narratives:
- CEO transition risk/opportunity: Hollub's June 1 retirement is the dominant near-term narrative — bulls see clean-slate optionality with Jackson; bears worry about losing the architect of CrownRock and OxyChem strategy.
- Stratos DAC commercialization: Q2 2026 startup is being watched as a potential re-rating catalyst; CDR offtake with Airbus, Amazon, AT&T, Microsoft gives institutional legitimacy.
- Debt paydown and FCF inflection: $5.8B debt cut post-OxyChem, 1.45M boe/d Permian production, $0.26/qtr dividend driving "show-me" FCF bulls into Q2.
- Notable voices:
- Warren Buffett (Berkshire Hathaway): Publicly silent in 2026 but actions speak — the $9.7B OxyChem buy + retained ~29% common is universally read as long-term endorsement of OXY's oil-weighted portfolio.
- Neal Dingmann (Truist Securities): Constructive on Permian cost structure post-CrownRock; sub-$40/bbl breakeven on incremental Midland Basin locations as a durable FCF floor.
- Roger Read (Wells Fargo): $72 PT; bullish on FCF/buyback bridge into H2 2026; flagged Jackson's Permian operational background as continuity positive.
- Sentiment shift (past 30 days): Shifted from cautiously bullish to actively bullish. The +10.16% weekly move was driven by Q1 earnings beat, Hormuz-related crude spike to $117/bbl Brent, and short-covering after the April 17 downgrade-driven selloff.
- Sentiment score: 3.8 / 5
11. Bull vs Bear Case
| Bull Case | Bear Case |
|---|---|
| Berkshire 29% stake + $59.62 warrant strike provides structural floor and standing M&A option | Berkshire could pause additions; warrant overhang dilutes at exercise |
| Stratos DAC commercial startup Q2 2026 unlocks $90M+/yr 45Q revenue; multiple-expansion event | DAC delayed multiple times already; commercial-scale tech has never operated; cost overruns likely |
| Debt down $7.5B in 7 months; $10B target unlocks buyback initiation by year-end 2026 | $13.3B remaining debt is still elevated per-bbl vs. peers; rates re-acceleration would stretch timeline |
| 6.42x EV/EBITDA vs. CVX 10.8x / XOM 12.0x — cheapest large-cap E&P with above-peer acreage | OxyChem removal raises pure crude beta; no refining buffer in oil downturn |
| Permian breakeven $40–45/bbl WTI; multi-decade inventory at 1.45M boe/d | EIA forecasts WTI $89→$65–75 by Q4 2026; sustained sub-$60 print compresses FCF below $2.5B |
| 8%+ dividend hike Feb 2026 to $0.26/qtr signals management confidence in FCF | CEO transition June 1: Hollub architect of CrownRock/OxyChem strategy departs |
| ADNOC/XRG South Texas DAC hub JV adds optionality on top of Stratos | Voluntary carbon market remains illiquid; offtake pricing could compress |
12. The Verdict
| Item | Value |
|---|---|
| Rating | BUY |
| Fair Value | $67 (+14.7% upside) |
| 12-Month Price Target | $65 (+11.3%) |
| Entry Zone | $45.00 – $50.00 (preferred); $55–58 acceptable for size building |
| Stop Loss | $38.00 (just below S1 $38.92) |
| Take-Profit Targets | T1: $66 (R1 retest) |
| Position Sizing | Scale in 1/3 lots — avoid full size at current $58.42 print per Ant's "wait for pullback" |
| Conviction | Medium |
| Time Horizon | 12–18 months |
| Key Catalyst to Watch | Stratos DAC startup Q2 2026 + $10B debt milestone Sep–Oct 2026 |
| Key Risk | Sustained WTI <$60/bbl driven by OPEC+ adds or weaker global demand — compresses FCF below $2.5B, defers buyback, pulls stock back to $45–50 |
Synthesis: OXY is a high-quality Permian operator with three unique structural features — the Berkshire put, the DAC carbon-management option, and an accelerating deleveraging arc — that the market still discounts. Fundamentals support a $67 fair value; the technical setup (Phase C late-markup, $58 just below R1 $66) argues for patience. The right play is to build the position on weakness toward $45–50 with the Q2 Stratos startup and Q3 debt milestone as the next re-rating catalysts. The single-largest downside is crude price — manage exposure accordingly.
Disclaimer: For informational purposes only. Not investment advice.